ArticleInvestigational new drugs2022

Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro.

Bernhard J Jank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.